Abstract
Bidens pilosa L. (Asteraceae) is routinely used in African pharmacopoeia for the management of inflammations, diarrhoea and cardiovascular disorders including hypertension. The implication of β-adrenomimetic agonist substances in the hypotension and vasodilatation induced by a chromatographic active fraction F2 of the leaves aqueous extract (BpF2) were investigated. BpF2 induced a dose-dependent hypotension (1 mg/kg b.w.- 25 mg/kg b.w.) in the rabbit. It caused a concentration dependent (10-12 mg/ml- 10-1 mg/ml) decrease in the force of contraction of the isolated guinea-pig aorta. The hypotension and vasodilatation elicited by BpF2 were attenuated in the presence of propranolol (a β-adrenoceptor antagonist). The results suggest that BpF2 could contain β-adrenomimetic agonist substances that may be partly responsible for the hypotension and the vasodilatation. This would therefore justify the use of the plant to treat hypertension.
Keywords: β-adrenomimetic agonists, propranolol, hypotension, vasodilatation
Current Bioactive Compounds
Title: β-Adrenomimetic Actions in the Hypotension and Vasodilatation Induced by a Chromatographic Active Fraction from Bidens pilosa L. (Asteraceae) in Mammals
Volume: 4 Issue: 1
Author(s): Kouakou Kouakou Leandre, Abo Kouakou Jean Claude, Datte Yao Jacques, Traore Flavien and Ehile Ehouan Etienne
Affiliation:
Keywords: β-adrenomimetic agonists, propranolol, hypotension, vasodilatation
Abstract: Bidens pilosa L. (Asteraceae) is routinely used in African pharmacopoeia for the management of inflammations, diarrhoea and cardiovascular disorders including hypertension. The implication of β-adrenomimetic agonist substances in the hypotension and vasodilatation induced by a chromatographic active fraction F2 of the leaves aqueous extract (BpF2) were investigated. BpF2 induced a dose-dependent hypotension (1 mg/kg b.w.- 25 mg/kg b.w.) in the rabbit. It caused a concentration dependent (10-12 mg/ml- 10-1 mg/ml) decrease in the force of contraction of the isolated guinea-pig aorta. The hypotension and vasodilatation elicited by BpF2 were attenuated in the presence of propranolol (a β-adrenoceptor antagonist). The results suggest that BpF2 could contain β-adrenomimetic agonist substances that may be partly responsible for the hypotension and the vasodilatation. This would therefore justify the use of the plant to treat hypertension.
Export Options
About this article
Cite this article as:
Leandre Kouakou Kouakou, Jean Claude Kouakou Abo, Jacques Yao Datte, Flavien Traore and Etienne Ehouan Ehile, β-Adrenomimetic Actions in the Hypotension and Vasodilatation Induced by a Chromatographic Active Fraction from Bidens pilosa L. (Asteraceae) in Mammals, Current Bioactive Compounds 2008; 4 (1) . https://dx.doi.org/10.2174/157340708784533438
DOI https://dx.doi.org/10.2174/157340708784533438 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands
Current Neuropharmacology Disentangling the Intricacies of Migraine: A Review
CNS & Neurological Disorders - Drug Targets The Use of TNF Family Ligands and Receptors and Agents which Modify their Interaction as Therapeutic Agents
Current Drug Targets Hypertension in the Elderly: An Evidence-based Review
Current Pharmaceutical Design Cerebral Artery Signal Transduction Mechanisms: Developmental Changes in Dynamics and Ca<sup>2+</sup> Sensitivity
Current Vascular Pharmacology The Role of Venous Abnormalities in Neurological Disease
Reviews on Recent Clinical Trials Difference in Blood Pressure Measurements Between Arms: Methodological and Clinical Implications
Current Pharmaceutical Design Hypersensitivity Reactions to Anticoagulant Drugs
Current Pharmaceutical Design Revised Roberts Cytoprotection and Adaptive Cytoprotection and Stable Gastric Pentadecapeptide BPC 157. Possible Significance and Implications for Novel Mediator
Current Pharmaceutical Design The Guanylyl Cyclase Inhibition by MB as Vasoplegic Circulatory Shock Therapeutical Target
Current Drug Targets Immunotherapy in Bladder Cancer
Current Molecular Pharmacology Mechanisms of Action and Chemical-Biological Interactions Between Ozone and Body Compartments: A Critical Appraisal of the Different Administration Routes
Current Drug Therapy The Renin Angiotensin System in the Regulation of Angiogenesis
Current Pharmaceutical Design Clinical Management of the Cardiovascular Failure in Sepsis
Current Vascular Pharmacology Intrathecal Apelin-13 Produced Different Actions in Formalin Test and Tail-flick Test in Mice
Protein & Peptide Letters Calcium as a Molecular Target in Angiogenesis
Current Pharmaceutical Design Critical Roles for Bradykinin and Prostanoids in Acute Inflammatory Reactions: A Search Using Experimental Animal Models
Current Drug Targets - Inflammation & Allergy Fibromyalgia: The Prototypical Central Sensitivity Syndrome
Current Rheumatology Reviews microRNAs: Innovative Targets for Cerebral Ischemia and Stroke
Current Drug Targets Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art
Current Drug Targets